Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study

Shen, Zhanlei1,2; Li, Quanman1,2; Wu, Jian1,2; Zhu, Dongfang1,2; Bai, Junwen1,2; Ren, Ruizhe1,2; Zhang, Jingbao1,2; Li, Yi1,2; Wang, Meiyun3; Gu, Jianqin4; Li, Yinfei3; Dong, Wenyong3; Wang, Haipeng5; Sun, Tao6; Yang, Fan7; Zhou, Xue8; Yang, Jian9; Tarimo, Clifford Silver1,2; Ma, Mingze1,2; Feng, Yifei1,2; Miao, Yudong1,2

2024-07-01

10.1002/jmv.29800

JOURNAL OF MEDICAL VIROLOGY   影响因子和分区

0146-6615

1096-9071

Globally, the rollout of COVID-19 vaccine had been faced with a significant barrier in the form of vaccine hesitancy. This study adopts a multi-stage perspective to explore the prevalence and determinants of COVID-19 vaccine hesitancy, focusing on their dynamic evolutionary features. Guided by the integrated framework of the 3Cs model (complacency, confidence, and convenience) and the EAH model (environmental, agent, and host), this study conducted three repeated national cross-sectional surveys. These surveys carried out from July 2021 to February 2023 across mainland China, targeted individuals aged 18 and older. They were strategically timed to coincide with three critical vaccination phases: universal coverage (stage 1), partial coverage (stage 2), and key population coverage (stage 3). From 2021 to 2023, the surveys examined sample sizes of 29 925, 6659, and 5407, respectively. The COVID-19 vaccine hesitation rates increased from 8.39% in 2021 to 29.72% in 2023. Urban residency, chronic condition, and low trust in vaccine developer contributed to significant COVID-19 vaccine hesitancy across the pandemic. Negative correlations between the intensity of vaccination policies and vaccine hesitancy, and positive correlations between vaccine hesitancy and long COVID, were confirmed. This study provides insights for designing future effective vaccination programs for emerging vaccine-preventable infectious X diseases.

China COVID-19 vaccination dynamic evolution vaccine hesitancy

SCI

英语

其他

Virology

Virology

WOS:001279358500022

WILEY

MICROBIOLOGY

Web of Science

1.Zhengzhou Univ, Coll Publ Hlth, Dept Hlth Management, 100 Kexue Rd, Zhengzhou 450001, Henan, Peoples R China
2.Henan Prov Engn Res Ctr Hlth Econ & Hlth Technol A, Zhengzhou, Peoples R China
3.Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Zhengzhou, Henan, Peoples R China
4.Southern Univ Sci & Technol, Sch Med, Shenzhen, Guangdong, Peoples R China
5.Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
6.Hangzhou Normal Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Hangzhou, Peoples R China
7.Fudan Univ, Sch Publ Hlth, NHC Key Lab Hlth Technol Assessment, Shanghai, Peoples R China
8.Mudanjiang Med Univ, Coll Hlth Management, Mudanjiang, Heilongjiang, Peoples R China
9.Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing, Peoples R China

Shen, Zhanlei,Li, Quanman,Wu, Jian,et al. Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study[J]. JOURNAL OF MEDICAL VIROLOGY,2024,96(7).

Shen, Zhanlei.,Li, Quanman.,Wu, Jian.,Zhu, Dongfang.,Bai, Junwen.,...&Miao, Yudong.(2024).Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study.JOURNAL OF MEDICAL VIROLOGY,96(7).

Shen, Zhanlei,et al."Dynamic evolution of COVID-19 vaccine hesitancy over 2021-2023 among Chinese population: Repeated nationwide cross-sectional study".JOURNAL OF MEDICAL VIROLOGY 96.7(2024).